Rabavert rabies vacc w-diluents
Ended Awarded
- Contract number
- SPE2DB25FTKQP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,506
Award facts
- Contract value 100% obligated
- $13,506.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,506.00 by the Defense Logistics Agency on September 9, 2025. The contract, which has no set-aside designation, covers the supply of Rabavert rabies vaccine with diluents to support Department of Defense medical supply needs. Performance will be completed by September 10, 2025, at the contractor's Park Ridge, Illinois facility. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its portfolio of contract awards with the Defense Logistics Agency. The company's core business involves distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare facilities across the nation. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets while maintaining a robust track record of delivering specialized pharmaceutical products ranging from vaccines to oncology treatments and other critical medical supplies to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FTKQP?
SPE2DB25FTKQP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FTKQP worth?
The government has obligated $13,506 on SPE2DB25FTKQP.
Is contract SPE2DB25FTKQP an order under another contract?
Yes. SPE2DB25FTKQP is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKQP competed?
The extent of competition for SPE2DB25FTKQP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award